Cisplatin News and Research

RSS
FDA approves Tarceva (erlotinib)

FDA approves Tarceva (erlotinib)

FDA fast tracks investigational anti-cancer drug, phenoxodiol

FDA fast tracks investigational anti-cancer drug, phenoxodiol

Alimta approved as first treatment for Mesothelioma, a deadly cancer caused by asbestos

Alimta approved as first treatment for Mesothelioma, a deadly cancer caused by asbestos

Study hints at antioxidants being able to prevent and restore hearing loss

Study hints at antioxidants being able to prevent and restore hearing loss

Aggressive treatment for nasopharyngeal cancer shown to be more effective

Aggressive treatment for nasopharyngeal cancer shown to be more effective

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells

Study may help oncologists tailor chemotherapy to patients based on their genetic make-up

Study may help oncologists tailor chemotherapy to patients based on their genetic make-up

Drug combo effective for advanced breast cancer

Drug combo effective for advanced breast cancer

Discovery of molecular switch could lead to new treatments for lymphoma and other forms of cancer

Discovery of molecular switch could lead to new treatments for lymphoma and other forms of cancer

Myriad Genetics advances drug for chemotherapy-induced nausea

Myriad Genetics advances drug for chemotherapy-induced nausea

NeoRx Corporation acquires worldwide rights to platinum-based anti-cancer agent

NeoRx Corporation acquires worldwide rights to platinum-based anti-cancer agent